With the goal of studying the immunogenicity of MUC1 in vivo and of developing MUC1-based cancer immunotherapy, human MUC1 transgenic mouse (TG mice) tumor models were set up by the group of Papadimitriou [32]. Here, MUC1 is linked to neoplasm.